Clinical trial NCT02049359: Short Messaging Service for Optimizing Hemoglobin A1C Management in Low-Income Diabetics
Official title: Use of a Short Messaging Service for Optimizing Hemoglobin A1C Management in Low-Income Diabetic Patients (SAMI TRIAL)
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Diabetes
Keywords: Diabetes
Lead sponsor: Campbell University, Incorporated
Sponsor class: OTHER
First posted: 2014-01-30
Enrollment: 170
Sex: ALL
Minimum age (years): 18
Maximum age (years): 80
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: SUPPORTIVE_CARE

Brief summary: The purpose of this study is to determine the impact of two-way short message service (SMS) on glycemic control in low-income, poorly-controlled adult diabetic patients.

Detailed description: This multi-center, unblinded, prospective randomized controlled trial will enroll adult diabetic patients of the Wilson Community Health Center, Harvest Family Health Center, and Freedom Hill Community Health Center living below 200% of 2013 poverty level with a serum hemoglobin A1C \>9% and who currently own a mobile device with text messaging capacity. After written informed consent has been obtained, subjects will be randomized to intervention or control group (1:1), stratified based on insulin initiation within 1 week of study inclusion. Participants randomized to the intervention group will be further divided into subgroups as "insulin user" or "non-insulin user" and both will receive SMS messages every 7 days. The content of the message consist of medication reminders, reporting of blood glucose results, insulin technique assessment (if applicable), or d) medication adherence assessment. Participants will be asked to respond with a simple text within 7 days. The intervention group will receive the standard medical appointment reminder via telephone one to two business days prior to the appointment at the Health Center PLUS a unidirectional text message two business days prior to scheduled health center appointments. Control group participants will receive the standard medical appointment reminder via telephone one to two business days prior to the appointment at the health center. All participants in the study (control and intervention) will undergo venipuncture at 3 months (+/-) 2 weeks for the determination of hemoglobin A1C. Demographic information, and frequency of hemoglobin A1C concentrations in the past 6 months will be assessed at baseline. Each week for 12 weeks, the number of texts sent per week and by type, percent of respondents weekly by text or by phone, content of participant responses, number of patients unable to be reached via text, total investigator time spent per week, and time spent per contact will be recorded. At the three month visit, the hemoglobin A1C concentration, blood transfusions since study initiation, and medication changes will be recorded.

Eligibility criteria: Inclusion Criteria:

* New or existing patient of Carolina Family Health Centers Inc. (Wilson Community Health Center, Harvest Family Health Center, Freedom Hill Community Health Center)
* Diagnosis of diabetes
* Single serum hemoglobin A1C equal to or greater than 9% within 2 weeks of study enrollment
* Below 200% of 2013 poverty level
* Currently own a mobile device with text messaging capacity and anticipated service for duration of 12 week study period

Exclusion Criteria:

* Anemia diagnosed within past 3 months
* Blood transfusion within the past 3 months
* unable to read English at the fifth grade level

Primary outcomes:
measure: Change From Baseline A1C
timeFrame: 12 weeks
Secondary outcomes:
measure: Change in A1C Based on Age, Gender, Race, Type and Duration of Diabetes
timeFrame: 12 weeks
Other outcomes:
Locations:
city: Elm City
country: United States
facility: Harvest Family Health Center
state: North Carolina
city: Tarboro
country: United States
facility: Freedom Hill Community Health Center
state: North Carolina
city: Wilson
country: United States
facility: Wilson Community Health Center
state: North Carolina
Study officials:
affiliation: Campbell University/Wilson Community Health Center
name: Jennifer D Smith, PharmD
role: PRINCIPAL_INVESTIGATOR
affiliation: Campbell University/Duke University
name: Richard Drew, PharmD
role: STUDY_DIRECTOR
References: